Pieris Pharmaceuticals Inc (PIRS)
16.64
+0.71
(+4.44%)
USD |
NASDAQ |
Nov 22, 16:00
16.64
0.00 (0.00%)
After-Hours: 16:19
Pieris Pharmaceuticals Shareholders Equity (Quarterly): 16.27M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 16.27M |
| June 30, 2024 | 18.70M |
| March 31, 2024 | 21.96M |
| December 31, 2023 | 26.76M |
| September 30, 2023 | 30.51M |
| June 30, 2023 | 40.50M |
| March 31, 2023 | 15.46M |
| December 31, 2022 | 27.93M |
| September 30, 2022 | 35.77M |
| June 30, 2022 | 44.36M |
| March 31, 2022 | 53.45M |
| December 31, 2021 | 50.76M |
| September 30, 2021 | 53.85M |
| June 30, 2021 | 46.72M |
| March 31, 2021 | 38.24M |
| December 31, 2020 | 31.03M |
| September 30, 2020 | 43.69M |
| June 30, 2020 | 46.67M |
| March 31, 2020 | 49.81M |
| December 31, 2019 | 51.35M |
| September 30, 2019 | 20.64M |
| June 30, 2019 | 19.48M |
| Date | Value |
|---|---|
| March 31, 2019 | 30.16M |
| December 31, 2018 | 39.94M |
| September 30, 2018 | 50.26M |
| June 30, 2018 | 55.32M |
| March 31, 2018 | 50.69M |
| December 31, 2017 | 11.52M |
| September 30, 2017 | 4.558M |
| June 30, 2017 | 9.334M |
| March 31, 2017 | 18.04M |
| December 31, 2016 | 25.23M |
| September 30, 2016 | 31.48M |
| June 30, 2016 | 37.29M |
| March 31, 2016 | 27.18M |
| December 31, 2015 | 31.13M |
| September 30, 2015 | 33.65M |
| June 30, 2015 | 11.15M |
| March 31, 2015 | 14.23M |
| September 30, 2014 | -0.0009M |
| June 30, 2014 | 0.01M |
| March 31, 2014 | -0.0048M |
| December 31, 2013 | -0.0032M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
15.46M
Minimum
Mar 2023
53.85M
Maximum
Sep 2021
37.19M
Average
39.37M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 841.18M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.52M |
| Total Liabilities (Quarterly) | 4.254M |